Subscribe
Home
Issues
Latest Issue
Issue Archive
Special Issues
2022 Midyear Review: Non–Small-Cell Lung Cancer
2022 Oncology Biosimilar Guide to Patient Support Services
2022 Breast Cancer Guide to Patient Support Services
Browse By Topic
Practice Management
Financial Management
Reimbursement
Health Policy
Quality Care
ICD Codes
Survivorship
FDA Approvals, News & Updates
In the News
Guide to Patient Support Services
Index
Introduction
2023 Spotlight: Amgen
Conference Correspondent
ASCO 2022 - Wrap Up
NSCLC IO 2022 - Midyear Review
SABCS 2021 Wrap-Up
Dual IO 2021 Year in Review
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Rapid Reactions
In the News
Quick Quiz
Multiple Myeloma Monthly Minutes
Melanoma Monthly Minutes
Press Releases
Women's Health Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes
Browse By Topic
Reimbursement
Reimbursement
Filter by Topic
Affordable Care Act
Coding and Billing
ICD Codes
Dispelling Misconceptions About HCC Coding
By
Karyn M. Dyehouse, MD
Coding and Billing
,
Reimbursement
Oncologists are operating in a whole new world as healthcare transitions to value-based care. To thrive in this emerging environment, providers must understand the many details involved in how value-based models work.
Read Article ›
Medications Used for the Treatment of Bladder Cancer and Associated ICD-10 Coding
By
Kristin A. Esposito, CPhT
Cancer Drug Coding
,
ICD Codes
,
Reimbursement
This detailed article of codes related to bladder cancer is intended to assist practice managers and other healthcare providers and payers to ensure the proper use of coding and billing information associated with the treatment of patients with bladder cancer.
Read Article ›
Medications Used for the Treatment of Lung Cancer and Associated ICD-10 Coding
By
Kristin A. Esposito, CPhT
Cancer Drug Coding
,
ICD Codes
,
Reimbursement
This detailed article of codes related to lung cancer is intended to assist practice managers and other healthcare providers and payers to ensure the proper use of coding and billing information associated with the treatment of patients with lung cancer.
Read Article ›
How Your Oncology Practice Can Thrive with MACRA: Get Ready for the Quality Payment Program
By
Meg Barbor, MPH
Reimbursement
By now all oncologists know that the implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) is shifting physician reimbursement from a volume- to a value-based model. To succeed with MACRA, practices must become familiar with how this will affect them and get ready to incorporate the new measures to ensure they get the best level of reimbursement under this program.
Read Article ›
Medications Used for the Treatment of Prostate Cancer and the Associated ICD-10 Codes
By
Kristin A. Esposito, CPhT
Cancer Drug Coding
,
ICD Codes
,
Reimbursement
This detailed article of codes related to prostate cancer is intended to assist practice managers and other healthcare providers and payers to ensure the proper use of coding and billing information associated with the treatment of patients with prostate cancer.
Read Article ›
A New Prior Authorization Decision-Support Tool Can Reduce the Costs of Cancer Treatment
By
Dana Taylor
Reimbursement
Cancer drug costs are escalating at an even faster rate, at least in part because of accelerated new approvals by the FDA and higher drug unit costs.
Read Article ›
Business of Practice 2017: Maximize Your MIPS Success
By
Chase Doyle
;
Chase Doyle
Professional Development
,
Professional Development
,
Reimbursement
Read Article ›
ASCO’s New Patient-Centered Oncology Payment Model
By
Meg Barbor, MPH
Reimbursement
The American Society of Clinical Oncology (ASCO) has developed a proposal for an Alternative Payment Model that is focused on delivering value in oncology and supporting higher-quality and more affordable cancer care.
Read Article ›
Growing Pains in Quality Reporting Measures Affect Your Reimbursement Rates
By
Meg Barbor, MPH
Reimbursement
“Are we really measuring quality, or are we measuring our ability to report?” asked Brian R. Bourbeau, MBA, Director, Practice Operations, Oncology Hematology Care, the US Oncology Network, Cincinnati, OH. “So far it’s been the latter,” he said.
Read Article ›
Medications Used for the Treatment of Melanoma (Skin Cancer) and Associated ICD-10 Codes
By
Kristin A. Esposito, CPhT
Cancer Drug Coding
,
ICD Codes
,
Reimbursement
This detailed article of codes related to melanoma (skin cancer) is intended to assist practice managers and other healthcare providers and payers to ensure the proper use of coding and billing information associated with the treatment of patients with melanoma
Read Article ›
Page 1 of 8
1
2
3
4
5
6
7
8
View the Latest Issue of OPM
Read Issue
Top Trending Articles
1.
Specialty Carve-Out Models Cost Patients and Employers More Than They Disclose
By
Dawn Holcombe, MBA, FACMPE, ACHE
2.
Best Practices: Education for Patients with Advanced NSCLC Treated with Immune Checkpoint Inhibitors
By
Marianne Davies, DNP, ACNP, AOCNP, FAAN
;
Shawn Perkins, RN, BSN, OCN
3.
Dexamethasone-Sparing Regimen Safe and Effective in Frail Patients with Multiple Myeloma
By
William King
Home
Issues
Latest Issue
Issue Archive
Special Issues
2022 Midyear Review: Non–Small-Cell Lung Cancer
2022 Oncology Biosimilar Guide to Patient Support Services
2022 Breast Cancer Guide to Patient Support Services
Browse By Topic
Practice Management
Financial Management
Reimbursement
Health Policy
Quality Care
ICD Codes
Survivorship
FDA Approvals, News & Updates
In the News
Guide to Patient Support Services
Index
Introduction
2023 Spotlight: Amgen
Conference Correspondent
ASCO 2022 - Wrap Up
NSCLC IO 2022 - Midyear Review
SABCS 2021 Wrap-Up
Dual IO 2021 Year in Review
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Rapid Reactions
In the News
Quick Quiz
Multiple Myeloma Monthly Minutes
Melanoma Monthly Minutes
Press Releases
Women's Health Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes